A start-up that launched only 8 months ago has attracted the attention of Biogen, a major developer of neurological drugs.

By end-user, the pharmaceutical and biotechnology companies segment accounted for the highest revenue-grossing segment in the global RNA interference (RNAi) market in 2023 owing to the significant ...

Dublin, April 17, 2025 (GLOBE NEWSWIRE) -- The "RNA Interference Market by Type, by Application, by End-user, and by Region" report has been added to ResearchAndMarkets.com's offering. The global RNA ...

Selection of the right study material is vital for success in the GATE Biotechnology exam. Here we are providing a list of some highly recommended books for GATE Biotechnology syllabus paper.

Two papers in this issue 1,2 show the potential of using RNA interference (RNAi) induced by hairpin RNAs as a new line of defense against coleopteran and lepidopteran pests. Baum et al.

01. Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

Leafhoppers evade predators using nanostructured brochosomes that reduce ultraviolet reflectance through morphology shaped by four novel structural proteins originating from evolutionary ...

With a Price to Book ratio of 4.44 ... to-equity ratio of 0.1. Key Takeaways For Regeneron Pharmaceuticals in the Biotechnology industry, the PE, PB, and PS ratios are all low compared to peers ...

Most plants and fungi have an innate defense against viruses that chops up their genetic material. Called RNA interference (RNAi), scientists have long debated whether the same mechanism exists in ...